Found 5 matching trials
Bioequivalence Study of Paroxetine Immediate Release (IR) Tablets Manufactured in GlaxoSmithKline Tianjin (GSKT) and Mississauga Sites in Healthy Chinese Subjects PHASE1 Paroxetine is a selective serotonin reuptake inhibitor (SSRI) and paroxetin...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Clinical Study to Investigate the Effect of the Combination of Psychotropic Drugs and an Opioid on Ventilation PHASE1 Opioids can decrease breathing and co-administration of benzodiazepines wit...
Show More Location
Spaulding Clinical Research
Learn More & Join Trial
Controlled-release Paroxetine in Major Depressive Disorder (Double-blind, Placebo-controlled Study) PHASE3 This is a randomized, double-blind, placebo-controlled, parallel group stud...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Repeat Dose Study of Controlled-Release Paroxetine Tablets and Immediate-Release Paroxetine Tablets in Healthy Japanese Male Subjects PHASE1 The primary purpose of this study is to compare the steady-state pharmacoki...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment PHASE3 To evaluate the long-term efficacy and safety of brexpiprazole as an adjunc...
Show More Learn More & Join Trial